Patient Group Pushes FDA For LASIK Ban

 
• By Elizabeth Orr

A group of patient advocates including one former US FDA official met with agency staff on Sept. 13 to raise awareness about adverse events tied to LASIK surgery. The group said the vision-correcting procedure is too risky to be offered as elective surgery.

MT1809_Eye Surgery_1064124212_1200.jpg
• Source: Shutterstock

A patient advocacy group met with US FDA officials Sept. 13 to advocate for new safety measures, if not a total ban, around LASIK eye surgery.

Retired FDA neuroscientist Morris Waxler and patient advocate Paula Cofer head the group. Waxler was on the original LASIK approval...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation